Description

6-(4-Biphenylyl)-2,3,4,12,13-Pentamethoxy-9,10-Dihydro-7H-Isoquino(2,1-D)(1,4)Benzodiazepine CAS NO 82802-94-6 is a complex, polycyclic organic compound belonging to the isoquinobenzodiazepine class, characterized by its biphenyl and multiple methoxy substituents. This compound is of significant interest in advanced organic synthesis and pharmaceutical research, serving as a sophisticated chemical intermediate or reference standard for developing novel therapeutic agents. It is primarily required by research institutions, pharmaceutical R&D laboratories, and specialty chemical manufacturers engaged in medicinal chemistry and heterocyclic compound synthesis.

Application

• Pharmaceutical Intermediate: A key building block in the research and development of new drug candidates, particularly those targeting the central nervous system.
• Medicinal Chemistry Research: Used as a core scaffold or precursor for synthesizing novel benzodiazepine and isoquinoline analogs with potential biological activity.
• Reference Standard: Serves as a high-purity analytical standard for method development, quality control, and identification in pharmaceutical analysis.
• Biochemical Tool Compound: Employed in pharmacological studies to investigate receptor binding interactions and structure-activity relationships (SAR).
• Advanced Organic Synthesis: Utilized in complex multi-step syntheses to construct intricate polycyclic frameworks for material science or agrochemical research.
• Academic Research: A valuable compound for universities and research institutes studying heterocyclic chemistry, reaction mechanisms, and new synthetic methodologies.

Basic Information

Item	Information
Product Name	6-(4-Biphenylyl)-2,3,4,12,13-Pentamethoxy-9,10-Dihydro-7H-Isoquino(2,1-D)(1,4)Benzodiazepine
CAS No.	82802-94-6
Molecular Formula	C36H32N2O5
Molecular Weight	572.65 g/mol
Synonyms	6-(4-Biphenylyl)-2,3,4,12,13-pentamethoxy-9,10-dihydro-7H-isoquino[2,1-d][1,4]benzodiazepine; 6-(Biphenyl-4-yl)-2,3,4,12,13-pentamethoxy-9,10-dihydro-7H-isoquino[2,1-d][1,4]benzodiazepine; Isoquino[2,1-d][1,4]benzodiazepine derivative; Biphenylyl-pentamethoxy-isoquinobenzodiazepine; 82802-94-6; UNII-7W4F6S7D4I; 7H-Isoquino(2,1-d)(1,4)benzodiazepine, 6-(1,1'-biphenyl-4-yl)-2,3,4,12,13-pentamethoxy-9,10-dihydro-
EINECS	Contact for details

Quality Control

Our 6-(4-Biphenylyl)-2,3,4,12,13-Pentamethoxy-9,10-Dihydro-7H-Isoquino(2,1-D)(1,4)Benzodiazepine is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all test results are provided and available upon request. We adhere to cGMP principles where applicable to support its use in research and development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0% (Area %)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.